T1	Participants 771 870	CONCLUSION Iobitridol is a safe and effective nonionic contrast agent for contrast-enhanced body CT
T2	Participants 553 659	RESULTS There was no significant difference in imaging quality and side effects between the contrast media
T3	Participants 0 123	Iobitridol 300 compared to iopromide 300--a double-blind randomized phase-III study of clinical tolerance in total body CT.
T4	Participants 125 376	UNLABELLED PURPOSE, MATERIAL AND METHODS: The clinical safety of iobitriodol 300 mg I/ml and iopromide 300 mg I/ml were compared in a randomized double blind phase-III study conducted on 60 patients undergoing abdominal CT for a variety of indications
